Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by stanleyon Jan 30, 2013 5:36pm
159 Views
Post# 20914328

RE: Brigus What,s up with BRD's Price

RE: Brigus What,s up with BRD's Price

Josameyer2:

[S] Lurk & Learns understand that new buying will be the saving/salvation of BRD's down- trend.

We could be seeing short covering OR new buying, either way we will take the 3.5% increase.

Today's Closing Positions for C:BRD

House Bought $Val Ave Sold $Val Ave Net $Net
16 Paradigm 384,000 344,530 0.897 0 384,000 -344,530
88 Credential 38,000 33,440 0.88 0 38,000 -33,440
13 Instinet 27,800 24,764 0.891 18,600 16,624 0.894 9,200 -8,140
9 BMO Nesbitt 11,100 9,880 0.89 6,400 5,756 0.899 4,700 -4,124
79 CIBC 32,500 29,100 0.895 28,500 25,600 0.898 4,000 -3,500
124 Questrade 2,500 2,215 0.886 1,500 1,320 0.88 1,000 -895
70 Manulife 500 445 0.89 0 500 -445
14 ITG 500 445 0.89 0 500 -445
83 Mackie 10,440 9,310 0.892 9,950 8,878 0.892 490 -432
7 TD Sec 2,000 1,770 0.885 1,700 1,515 0.891 300 -255
19 Desjardins 2,000 1,780 0.89 2,000 1,800 0.90 0 20
57 Interactive 2,800 2,516 0.899 3,000 2,670 0.89 -200 154
80 National Bank 100 89 0.89 300 271 0.903 -200 182
85 Scotia 7,500 6,705 0.894 8,900 8,010 0.90 -1,400 1,305
62 Haywood 0 2,140 1,904 0.89 -2,140 1,904
72 Credit Suisse 0 6,600 5,932 0.899 -6,600 5,932
29 Casimir 79,500 71,255 0.896 88,000 78,620 0.893 -8,500 7,365
2 RBC 1,350 1,195 0.885 76,600 68,763 0.898 -75,250 67,568
33 Canaccord 500 440 0.88 86,000 76,410 0.888 -85,500 75,970
1 Anonymous 97,500 86,815 0.89 215,000 193,415 0.90 -117,500 106,600
73 Cormark 0 145,400 129,206 0.889 -145,400 129,206
TOTAL 700,590 626,694 0.895 700,590 626,694 0.895 0 0

Bullboard Posts